Accredited Investors Employee Shareholders Institutions Private Companies Who We Serve Trading and InvestingData SolutionsPrivate Asset Custody Institutional TradingForge ProTrade private companies with Forge’s institutional brokerage toolBrowse CompaniesIndividual InvestingForge MarketsFind new private company investment opportunitiesForge DataAnalyze private markets via Forge’s intuitive web applicationForge Private Market IndexMonitor a benchmark for actively traded private companies Forge Accuidity Private Market IndexInvest in an institutionally-managed diversified basket of private companies (QPs only)Self-Directed IRAForge TrustInvest in private companies and other alternative assets through a tax-advantaged Self-Directed IRASolutions All InsightsPrivate Market ReportsMarket InsightsBuying and Selling Pre-IPO All ReportsPrivate Market Updates Forge Investment OutlookStartup News and TrendsPrivate Market Data and AnalyticsTech IPO Calendar for 2024Private Market ExplainedBuying Pre-IPO SharesSelling Pre-IPO Shares Glossary Videos FAQsInsights About Us Leadership Investor Relations People & Culture Careers About

BillionToOne Stock

Q: How to sell BillionToOne stock?

If you hold private company shares of BillionToOne - whether as an employee or an early investor - Forge can help you sell them. 1. Create a free Forge account, this will give you access to Forge’s marketplace and to one of our experienced Private Market Specialist to answer any questions you might have. 2. Indicate your interest to sell your BillionToOne stock on our platform. 3. Work with your dedicated Private Market Specialist who’ll help guide you through every step of the transaction.

billiontoone.comHealthcare / BioTech & PharmaFounded: 2016Funding to Date: $407.89MM

BillionToOne is a molecular counter platform designed to accurately count DNA molecules to the single-count level. With a mission to detect disorders such as cystic fibrosis and sickle-cell disease, the company optimizes the signal-to-noise ratio through blood testing. The platform specializes in both prenatal and oncology divisions. BillionToOne was founded by David Tsao, Oguzhan Atay, and Sukrit Silas in 2016 and is headquartered in San Francisco, CA.

Buy or sell BillionToOne stockLearn more about BillionToOne IPO

OverviewFinancingsValuation

Enterprise Value

Access BillionToOne’s valuation and stock price.

View secondary pricing information, VWAP and distribution waterfall. And seek potentially outsized returns with same day private market data for private companies like BillionToOne.

Become part of the Secondary Marketplace, catering to both individual and institutional investors.

Access Stock Price

Animation displayed is not current and securities are shown for illustrative purposes only.

BillionToOne investors also invested in these private companies

Y Combinator

OpenAI, Helion Energy, Scale AI, Flock Safety, Mark Cuban Cost Plus Drug Company, Zapier, Rippling, Deel, Quora, Substack

Adams Street Partners

Glean, Arctic Wolf, BillionToOne, VillageMD, Couchbase, Abra, FalconX, GoCardless, Axonius, Homeward

Premji Invest

BillionToOne, Navan, Devoted Health, Hippocratic AI, MapBox, Apttus, Heyday, Enveda Biosciences, Bicara Therapeutics, Lenskart

Northwest Venture Partners

VAST Data, BillionToOne, ZineOne, You.com, Aisera

Hemisphere Ventures

Axiom Space, Bolt, Hologram, Zum, BillionToOne, Gecko Robotics, Nav, Side, Phil, Omaze

Neuberger Berman

Savage X Fenty, BillionToOne, Prosper, Caris Life Sciences, Gympass, Wayflyer, ProducePay, DoubleVerify, Anvilogic

Four Rivers Group

BillionToOne, Censys, Nimble Rx, Dtex, Nexenta Systems, ClimateAI, Rockset

Fifty Years

Upside Foods, Rad AI, BillionToOne, Antora Energy, Solugen, Athelas, Meati Foods, OpenTrons, Atom Computing, garten

500 Global

Innovaccer, Common, BillionToOne, Firefly Aerospace, Kin, Hornet, Intercom, Sentry, Kin Insurance, BabyList

UpHonest Capital

Rippling, BillionToOne, Botrista, Mashgin, Rescale, Torch, Mezmo, Fieldguide, Proven, The EVERY Company

Time BioVentures

Neuralink, BillionToOne

Start Capital

Figure AI, BillionToOne, Ample, TravelPerk, Evonetix, Figure AI

Metaplanet Holdings

Anthropic, CoinList, BillionToOne, Loyal, Fabric Cryptography, SmithRx, Unlikely AI, OpenTrons, Nanotronics, Improbable

Neotribe Ventures

BillionToOne, Aerospike, Vendia, Fortanix, ClimateAI

HOF Capital

xAI, Rimac Automobili, Varda Space Industries, BillionToOne, Insitro, Hunters, Asapp, SaltPay

Hummingbird Ventures

BillionToOne, Aspire, Enveda Biosciences

U.S. Department of Health and Human Services

BillionToOne, Epic Sciences, CytoVale, Scene Health, RefleXion Medical, Alamar Biosciences

Civilization Ventures

BillionToOne, Omada Health, Ample, Evonetix

NewDo Venture

BillionToOne, Jerry

QB3

BillionToOne, Attralus

Brightway Future Capital

Rippling, BillionToOne, Otter.ai

NYX Ventures Partners

BillionToOne, Pika

Lombardstreet Ventures

BillionToOne

Team

Management Team

Oguzhan Atay Ph.D

Co-Founder & Chief Executive Officer

David Tsao Ph.D

Co-Founder & Chief Technology Officer

Thomas Lynch JD

General Counsel & Chief Compliance Officer

Shan Riku

Chief Product Officer

Ross Taylor

Chief Financial Officer

Gary Palmer JD

Chief Medical Officer

Board Members

Akshay Rai

Premji Invest

Casper de Clercq

Norwest Venture Partners

Firat Ileri

Hummingbird Ventures

Swaroop Kolluri

Neotribe Ventures

Thomas Bremner

Adams Street Partners

BillionToOne stock FAQs

Can you buy BillionToOne stock?

As BillionToOne is not publicly traded, purchasing its stock is not available to everyone. To buy the stock of a private company like BillionToOne, you must be an accredited investor. If you meet the accreditation criteria, you can register for Forge’s Secondary Marketplace to buy private market stock. If you are not an accredited investor, discover how to begin the process to potentially qualify for new investment opportunities.

How to buy BillionToOne stock?

To invest in a private company like BillionToOne through Forge, you must first qualify as an accredited investor. (Learn more about the accreditation process.)

Create a free account to access Forge’s marketplace.
Express your interest in specific investments. Within Forge Markets, you will find detailed pricing and financing information for thousands of private companies.
Throughout this process, a dedicated Forge Private Market Specialist will be available to address any questions you may have and to guide you seamlessly through each step of the transaction.

Can you sell BillionToOne stock?

Yes, you may be able to sell your BillionToOne stock, subject to certain conditions. Forge can help you facilitate the sale of your stock in a manner that aligns with your needs and the company's interests. If you are looking for liquidity, register with us today to begin the process. A dedicated Forge Private Market Specialist will be available to address any questions you may have along the way.

How to sell BillionToOne stock?

If you hold private company shares of - whether as an employee or an early investor - Forge can help you sell them.

Create a free Forge account, this will give you access to Forge’s marketplace and to one of our experienced Private Market Specialist to answer any questions you might have.
Indicate your interest to sell your BillionToOne stock on our platform.
Work with your dedicated Private Market Specialist who'll help guide you through every step of the transaction.

Is BillionToOne a public company?

No, BillionToOne is a privately held company and is currently not publicly traded on any stock markets including NYSE or NASDAQ.

What is BillionToOne’s stock price?

BillionToOne is a privately held company and therefore does not have a public stock price. However, you may access BillionToOne’s private market stock price with Forge Data.

What is BillionToOne’s stock ticker symbol?

BillionToOne does not have an official ticker symbol because this company is not currently publicly traded.

Can institutional investors buy and sell private market stocks?

Yes. As one of the largest trading platform for the private market, Forge helps institutional investors seek liquidity as they buy and sell private stock for their portfolios or their clients. Our private market specialists have decades of experience working with institutional firms. Learn more or register today to get started.

Fierce Biotech 06/24/2024

DNA testmaker BillionToOne claims billion-dollar valuation with $130M funding round

In a series D funding round led by Premji Invest, BillionToOne raised $130 million.

Silicon Valley Daily 12/27/2022

BillionToOne Scores $48.5 Million - Silicon Valley Daily

BillionToOne, Inc., a molecular diagnostics company, has secured an additional $48.5 million of funding from existing equity investors as well as upsized its Term Loan Facility with access to up to $35 million, with its existing lender, Bridge Bank.

Browse More Insights

Frequently Asked Questions

Updated on: Jul 26, 2024

PLEASE READ THESE IMPORTANT LEGAL NOTICES & DISCLOSURES

Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.